Facebook
Twitter
Telegram
Report an Error9 Meters Biopharma Financial Statements 2011-2024 | NMTR
Annual Financial Statements 9 Meters Biopharma
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
17.5 M | 11.9 M | 147 M | 25.7 M | 57.2 M | 5.75 M | 9.23 M | - | - | - | - | - |
Shares |
13 M | 12.2 M | 106 M | 33.3 M | 24.8 M | 942 K | 552 K | - | - | - | - | - |
Historical Prices |
1.35 | 0.979 | 0.859 | 0.557 | 2.31 | 6.1 | 17.5 | - | - | - | - | - |
Net Income |
-43.8 M | -36.8 M | -61.5 M | -27 M | -24.2 M | -7.92 M | -6.21 M | -8.74 M | -11.1 M | -3.44 M | - | - |
Revenue |
- | - | - | - | - | 1.88 M | 4.06 M | 8.27 M | 11.3 M | 3.44 M | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | -64 K | 736 K | 426 K | 234 K | 606 K | - | - |
Operating Income |
-42 M | -36.8 M | -60.9 M | -25.5 M | 18.2 M | 11.2 M | -5.94 M | -6.46 M | - | - | - | - |
Interest Expense |
2.67 M | 47.2 K | 4.05 M | 1.83 M | 6.15 M | 436 K | 825 K | 1.38 M | - | - | - | - |
EBITDA |
-42 M | -36.8 M | -59.4 M | -24.3 M | -18.2 M | -6.54 M | -5.81 M | -6.41 M | -9.38 M | -3.36 M | - | - |
Operating Expenses |
42 M | 36.8 M | 60.9 M | 24.3 M | 18.2 M | 6.6 M | 6.68 M | 6.89 M | 6.91 M | 3.97 M | - | - |
General and Administrative Expenses |
11 M | 9.66 M | 10.5 M | 10.6 M | 10.7 M | 4.98 M | 3.98 M | 3.62 M | 2.65 M | 1.75 M | - | - |
All numbers in USD currency
Quarterly Income Statement 9 Meters Biopharma
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
13.6 M | 13 M | 13 M | 259 M | 12.9 M | 12.9 M | 12.7 M | 250 M | 211 M | 205 M | 142 M | 78.6 M | 41.2 M | 39.5 M | 35.9 M | 34 M | 27.3 M | 26.1 M | 25.8 M | 25.7 M | 21.2 M | 11.9 M | 31.5 M | 11.9 M | 11.9 M | 779 M | 6.91 M | 3.75 M | 3.75 M | 3.7 M | 3.29 K | 3.08 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-13.9 M | - | -9.35 M | -11.1 M | -11.4 M | - | -13.5 M | -8.25 M | -5.43 M | - | -8.33 M | -44.6 M | -3.6 M | - | -9.22 M | -4.49 M | -4.43 M | - | -776 K | -4.22 M | -15 M | - | -11.6 M | -11.6 M | -11.6 M | - | -1.83 M | -1.24 M | -1.88 M | - | -1.47 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -70 K | -39 K | -47 K | - | 92 K | 430 K | 47 K | - | 532 K | 86 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-12.8 M | - | -8.72 M | -11.2 M | -11.4 M | - | -13.5 M | -8.26 M | -5.4 M | - | -6.3 M | -44.8 M | -4.96 M | - | -6.51 M | -6.12 M | 4.31 M | - | -220 K | 3.38 M | 11.3 M | - | 2.34 M | 2.69 M | 3.92 M | - | -2.36 M | -901 K | -1.63 M | - | -1.39 M | -1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
753 K | - | 847 K | - | 304 | - | 1.97 K | 1.15 K | 44.1 K | - | 2.12 M | 1.02 M | 573 K | - | 472 K | 432 K | 427 K | - | 1.04 M | 894 K | 3.66 M | - | 111 K | 99.5 K | 71.6 K | - | 25 K | 339 K | 252 K | - | 75 K | 99 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-12.8 M | - | -8.71 M | -11.2 M | -11.4 M | - | -13.5 M | -8.26 M | -5.4 M | - | -6.29 M | -44.8 M | -4.95 M | - | -6.49 M | -6.11 M | 4.32 M | - | -205 K | 3.39 M | 11.3 M | - | 2.34 M | 2.69 M | 3.92 M | - | -2.27 M | -836 K | -1.6 M | - | -1.37 M | -1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
12.8 M | - | 8.72 M | 11.2 M | 11.4 M | - | 13.5 M | 8.26 M | 5.4 M | - | 6.3 M | 44.8 M | 4.96 M | - | 6.51 M | 6.12 M | 4.31 M | - | -220 K | 3.38 M | 11.3 M | - | 2.34 M | 2.69 M | 3.92 M | - | 2.46 M | 1.33 M | 1.68 M | - | 1.92 M | 1.14 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.99 M | - | 2.42 M | 3.65 M | 3 M | - | 2.39 M | 2.55 M | 2.21 M | - | 1.89 M | 5.66 M | 1.67 M | - | 2.56 M | 3.05 M | 3.11 M | - | 1.57 M | 2.13 M | 4.97 M | - | 1.97 M | 1.56 M | 2.58 M | - | 1.85 M | 675 K | 992 K | - | 1.32 M | 492 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency